Under-Representation of Diverse Populations and Glycemic Outcomes in Major Clinical Trials of Automated Insulin Delivery-Reference-Cited by-同舟云学术

Under-Representation of Diverse Populations and Glycemic Outcomes in Major Clinical Trials of Automated Insulin Delivery

Published:2023-10-01 Issue:10 Volume:25 Page:752-754
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

García-Tirado José¹²,Villard Orianne¹³,Hall Megan¹⁴^ORCID,Bisio Alessandro⁵^ORCID,Gonder-Frederick Linda¹⁶

Affiliation:

1. Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.

2. Department of Diabetes, Endocrinology, Nutritional Medicine, and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

3. Department of Endocrinology, Diabetes, and Nutrition, Montpellier University Hospital, Montpellier, France.

4. Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.

5. Novo Nordisk, Rome, Italy.

6. Department of Psychiatry, University of Virginia, Charlottesville, Virginia, USA.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0197

Reference6 articles.

1. Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center

2. Racial Disparities in Diabetes Technology Use and Outcomes in Type 1 Diabetes in a Safety-Net Hospital

3. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

4. Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial

5. Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of diabetes technology in children;Diabetologia;2024-07-12

2. Real-World Evidence of Automated Insulin Delivery System Use;Diabetes Technology & Therapeutics;2024-03-01

3. Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study;Diabetes Technology & Therapeutics;2024-01-01